ApoB-48 and apoB-100 differentially influence the expression of type-III hyperlipoproteinemia in APOE*2 mice (Q44138808)

30 November 2017

title

ApoB-48 and apoB-100 differentially influence the expression of type-III hyperlipoproteinemia in APOE*2 mice (English)

1 reference

30 November 2017

Myron E Hinsdale

1

1 reference

30 November 2017

Patrick M Sullivan

series ordinal

2

1 reference

30 November 2017

Hafid Mezdour

series ordinal

3

1 reference

30 November 2017

Nobuyo Maeda

series ordinal

4

1 reference

30 November 2017

publication date

1 September 2002

1 reference

Journal of Lipid Research

30 November 2017

published in

1 reference

30 November 2017

volume

43

1 reference

30 November 2017

issue

9

1 reference

30 November 2017

page(s)

1520-1528

1 reference

Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Apolipoprotein E and atherosclerosis: insight from animal and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Apo E structure determines VLDL clearance and atherosclerosis risk in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Apolipoprotein E competitively inhibits receptor-dependent low density lipoprotein uptake by the liver but has no effect on cholesterol absorption or synthesis in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Lipoproteins containing the truncated apolipoprotein, Apo B-89, are cleared from human plasma more rapidly than Apo B-100-containing lipoproteins in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Targeted modification of the apolipoprotein B gene results in hypobetalipoproteinemia and developmental abnormalities in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Two distinct apolipoprotein B alleles in mice generated by a single 'in-out' targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Altered wound healing in mice lacking a functional osteopontin gene (spp1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

The molecular mechanism for the genetic disorder familial defective apolipoprotein B100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Receptor-mediated mechanisms of lipoprotein remnant catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Doubling expression of the low density lipoprotein receptor by truncation of the 3'-untranslated region sequence ameliorates type iii hyperlipoproteinemia in mice expressing the human apoe2 isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Targeted Replacement of the Mouse Apolipoprotein E Gene with the Common Human APOE3 Allele Enhances Diet-induced Hypercholesterolemia and Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Direct determinations of plasma, cell, and organ-blood volumes in normal and hypervolemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Apolipoprotein E polymorphism and heterozygous familial hypercholesterolemia. Sex-specific effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Apolipoprotein E polymorphism and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Superior role of apolipoprotein B48 over apolipoprotein B100 in chylomicron assembly and fat absorption: an investigation of apobec-1 knock-out and wild-type mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Two distinct truncated apolipoprotein B species in a kindred with hypobetalipoproteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Regulation of the apolipoprotein B in heterozygous hypobetalipoproteinemic knock-out mice expressing truncated apoB, B81. Low production and enhanced clearance of apoB cause low levels of apoB

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

Inhibition of lipoprotein lipase by the receptor-binding domain of apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200103-JLR200

10.1194/JLR.M200103-JLR200

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference